Home / About us / ESG / Sustainability /
Green propellants
A growing body of research highlights the environmental impact of inhalation devices, making the need for sustainable solutions clear. We are committed to decarbonizing the global inhaler market by leading the transition to next-generation propellants. Our low Global Warming Potential (GWP) formulations deliver exceptional performance while minimizing environmental impact.
Green propellant pioneers
Building on our legacy of ushering in the current generation of propellants, we are committed to leading the transition to a greener future for inhalation therapies.
We’re at the forefront of commercial green propellant lines, with registration batches completed in 2024 and full commercial-scale operations in 2025.
Just as we led the transition from CFC- to HFA-based inhalers in the 1990s, developing the world’s first CFC-free pMDI and nasal pMDI, we are now driving the industry towards greener propellants. Our commitment to environmental responsibility extends beyond product development—we continually evaluate and refine our processes to minimize our ecological footprint.
A seamless green transition
Our adaptable components and hardware, combined with the expertise of our industry-leading team, ensure that new, greener devices match the performance of current ones. Throughout this process, we maintain our unwavering commitment to quality, safety and regulatory compliance.
Let’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.